Skip to main content
. Author manuscript; available in PMC: 2017 Feb 23.
Published in final edited form as: Clin Immunol. 2016 Jun 2;169:14–15. doi: 10.1016/j.clim.2016.06.001

Fig. 1.

Fig. 1

Positive C3 Nephritic Factor analysis. A: 3 parts normal serum, 1 part patient's serum, Mg++ and EDTA (alternative pathway activation possible); B. 3 parts normal serum + 1 part patient's serum + EDTA (alternative pathway activation not possible); C. Contains 3 parts buffer + 1 part patient's serum (control for patient's serum by itself).